This is a de facto change of control at a deeply distressed price (~$0.05/share implied). The new controlling group has board representation and can dictate strategy. Watch for potential reverse stock split to cure the Nasdaq bid price deficiency, further dilutive issuances, or a sale of the remaining shell. The stock is likely to trade at a significant discount to any residual asset value given the massive overhang and the group's low cost basis.
Price Chart
Executive Summary
A group of 19 non-U.S. investors, led by Chang Woei Jiann, acquired control of Aterian by purchasing convertible preferred shares from director David Elliot Lazar for $12 million. The preferred shares convert into approximately 241.9 million common shares, representing ~92.5% of the fully diluted outstanding stock. The transaction closed on September 25, 2026, and resulted in a board seat for the purchasers' designee, William H. Crampton, replacing a resigned director. The filing is a Schedule 13D by Chang Woei Jiann, who now beneficially owns ~10% of the outstanding common stock, but the broader group collectively controls the company.
Key Financial Metrics
Key Facts
- 19 non-U.S. investors purchased convertible preferred shares from director David Elliot Lazar for $12 million total.
- The preferred shares convert into 241,861,970 common shares, representing ~92.5% of the fully diluted outstanding stock.
- Chang Woei Jiann now beneficially owns 26,121,180 common shares, or ~10% of the outstanding common stock.
- William H. Crampton was appointed to the board as the purchasers' designee, replacing Avraham Ben-Tzvi.
- Aterian received a Nasdaq bid price deficiency notice on September 2, 2026, with a 180-day cure period ending March 1, 2027.
- The company completed an asset sale to Trademark Global, LLC on April 27, 2026, and is now a post-asset-sale entity with reduced operations.
Financial Impact
Massive dilution: the conversion of the purchased preferred shares adds ~241.9 million new common shares, increasing the fully diluted share count by ~925% from the pre-conversion base of ~26.1 million shares. The $12 million purchase price implies an effective price of ~$0.05 per underlying common share.
Risk Factors
- Massive dilution: the conversion of preferred shares increases the share count by ~925%, severely diluting existing common shareholders.
- Nasdaq delisting risk: the company received a bid price deficiency notice and has until March 1, 2027 to cure.
- Control by a group of non-U.S. investors with no disclosed track record or activist history creates significant governance uncertainty.
- Post-asset-sale company has limited ongoing business operations and may be a shell with minimal assets.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D Filing (Primary) | 0001437749-26-031910 |
| Document: 0001437749-26-031910-index-headers.html | 0001437749-26-031910 |
| Document: 0001437749-26-031910-index.html | 0001437749-26-031910 |
| Document: 0001437749-26-031910.txt | 0001437749-26-031910 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.6300 | awaiting T+5 | — | $0.6622 (+5.11%) |
Oct 5, 2026 21d ago | 8-K | $0.6425 $0.5705 | ▲ +11.21% | ▲ +11.07% | $0.6622 (−3.07%) |
Oct 2, 2026 24d ago | SC 13D | $0.6356 $0.6076 | ▲ +4.41% | ▲ +4.83% | $0.6622 (−4.19%) |
Oct 2, 2026 24d ago | SC 13D | $0.6356 $0.6076 | ▲ +4.41% | ▲ +4.83% | $0.6622 (−4.19%) |
Sep 29, 2026 26d ago | SC 13D/A | $0.5866 $0.6109 | ▼ −4.14% | ▼ −2.23% | $0.6622 (−12.89%) |
Jul 29, 2026 12w ago | 3 | $0.3900 $0.4610 | ▲ +18.21% | ▲ +14.58% | $0.6622 (+69.79%) |
Jul 20, 2026 14w ago | S-3 | $1.03 $0.3605 | ▲ +65.00% | ▲ +63.77% | $0.6622 (+35.71%) |
Jul 13, 2026 15w ago | DEFA14A | $1.19 $1.30 | ▲ +9.24% | ▲ +10.03% | $0.6622 (−44.35%) |
Jul 8, 2026 15w ago | Press Release | $1.19 $1.28 | ▲ +7.56% | ▲ +7.69% | $0.6622 (−44.35%) |
Jul 6, 2026 16w ago | DEFA14A | $1.31 $1.15 | ▼ −12.21% | ▼ −12.70% | $0.6622 (−49.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers